Tolvaptan is a racemate comprising of equimolar amounts of (R)- and (S)-tolvaptan. It is a selective vasopressin V2 receptor antagonist used to treat euvolemic and hypervolemic hyponatremia. It is also used to treat rapidly progressing autosomal dominant polycystic kidney disease to slow the rate of cyst development and renal insufficiency. Among its listed roles, it functions as a vasopressin receptor antagonist and an aquaretic. It includes a (S)-tolvaptan and a (R)-tolvaptan. It is grouped under the following drug class(es): Diuretics. Its therapeutic use is listed as hyponatremia agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include jinarc, Jynarque and tolvaptanum. Its PubChem CID is 216237.
Tolvaptan
| CAS No | 150683-30-0 |
|---|---|
| Molecular Formula | C26H25ClN2O3 |
| Molecular Weight | 448.9 g/mol |
| Synonyms | N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Tolvaptan is a racemate comprising of equimolar amounts of (R)- and (S)-tolvaptan. It is a selective vasopressin V2 receptor antagonist used to treat euvolemic and hypervolemic hyponatremia.
The listed CAS number is 150683-30-0.
The listed molecular formula is C26H25ClN2O3.
The listed molecular weight is 448.9 g/mol.
N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide.
The source lists jinarc, Jynarque and tolvaptanum.